您的位置: 首页 > 农业专利 > 详情页

2,4 di [(hetero) -arylamino] -pyrimidine derivatives as inhibitors of Zap-70 and / or SYK
专利权人:
NOVARTIS AG;NOVARTIS PHARMA GMBH
发明人:
BAENTELI, ROLF,BERNHARD, MARIE,BUEHLMAYER, PETER,COOKE, NIGEL,DUTHALER, RUDOLF,HINTERDING, KLAUS,THOMA, GEBHARD,VAN EIS, MAURICE,VON MATT, ANETTE,WALLISER, LOUIS,ZENKE, GERHARD
申请号:
ES10178291
公开号:
ES2487534T3
申请日:
2004.09.15
申请国别(地区):
ES
年份:
2014
代理人:
摘要:
A compound of the formula I Where (a) Z is>; = CR2; (b) R0 is hydrogen; halogen, C1-C4 unsubstituted alkyl, C1-4 unsubstituted alkoxy; (c) R1 is hydrogen; halogen, C1-C8 alkyl, C1-8 substituted alkyl; -SO2N (R10) R11; -N (C1-4 alkyl) C (O) C1-4 alkyl; a 5- or 6-membered heterocyclic ring optionally substituted on an N atom of the ring; C1-C8 alkoxy; phenyl; or R1 forms together with R2 and the C atoms to which R1 and R2 are attached, a 5-10 membered aryl or heteroaryl, the latter comprising 1 or 2 nitrogen atoms; or R1 and R2 together with the C atoms to which they are attached, a non-aromatic carbocyclic residue of 5 to 15 members; or R1 and R2 together with the C atoms to which they are attached, a 5 to 15 membered non-aromatic heterocyclic residue comprising 1 to 5 O atoms as heteroatoms; whose heterocyclic residue can be optionally substituted; (d) R2 is hydrogen; hydroxy; C1-C8 alkyl; C1-8 substituted alkyl; C1-8 alkoxy; C1-C4 alkoxy C1-C8 alkoxy; -CON (R10) R11; -SO2N (R10) R11; fluoro-C1-5 alkoxy comprising 2 to 5 fluorine atoms; C1-C8 C1-C8 alkoxy C1-C8 alkoxy; C2-C8 alkenyloxy; halo-C2-C8 alkenyloxy; benzyloxy; or -N (CH3) (R13), wherein R13 is methyl or benzyl; (e) R3 is SO2NR10R11; (f) R4 is hydrogen; or together with R3 and the N and C atoms to which R3 and R4 are attached a 6-membered heterocyclic ring; (g) R5 is hydrogen; halogen; C1-4 alkyl; or CF3; (h) R6 is hydrogen; (i) one of R10 and R11, independently, is hydrogen or C1-4 alkyl and the other is hydrogen; C1-8-alkyl; C1-8 substituted alkyl; a heterocyclic ring; C2-8 alkenyl; C3-8 cycloalkyl; C1-8 C1-4 alkoxy alkyl; or C1-8 hydroxy C1-8 alkoxy alkyl; (i) R7 is tetrahydropyran-2-ylmethoxy, tetrahydrofuran-2-ylmethoxy, thiazol-2-ylmethoxy, 2- (2-oxo-pyrrolidin-1-yl) -ethoxy, 3-pyridylmethoxy or phenyl, and R8 and R9 are each hydrogen; or (ii) R7 is 2-hydroxy-ethylamino and R8 is hydroxymethyl and R9 is hydrogen; or (iii) R7 is piperazin-1-yl, 4-isopropyl-piperazin-1-yl, 4- (2-methoxyethyl) -piperaz
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充